Shares of Henry Schein Inc. HSIC rose 2.23% to $74.59 Friday, on what proved to be an all-around favorable trading session ...

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

Meeting to be held on March 10 at 11 am hosted by Oppenheimer. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Henry Schein (HSIC – Research Report) today and set a price target of ...

QRG Capital Management Inc. lessened its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 13.2% during the 4th ...

Dental and medical products company Henry Schein (NASDAQ:HSIC) in Q4 CY2024, but sales rose 5.8% year on year to $3.19 ...

NasdaqGS:HSIC Earnings and Revenue History March 5th 2025 The Impact Of Unusual Items On Profit. For anyone who wants to understand Henry Schein's profit beyond the statutory numb ...

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ...

Dental and Medical products company Henry Schein (NASDAQ:HSIC) will be reporting results tomorrow morning. Here’s what ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Henry Schein has acquired R. Weinstein, Inc., a provider of vaccines, medical-surgical products and equipment to Hawaii-based health care facilities and practitioners.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...